Kimberly-Clark Corporation (KMB)
Automate Your Wheel Strategy on KMB
With Tiblio's Option Bot, you can configure your own wheel strategy including KMB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KMB
- Rev/Share 54.4424
- Book/Share 4.0145
- PB 24.7405
- Debt/Equity 5.4362
- CurrentRatio 0.7735
- ROIC 0.181
- MktCap 32963624281.0
- FreeCF/Share 7.2725
- PFCF 13.6608
- PE 16.7366
- Debt/Assets 0.4288
- DivYield 0.0507
- ROE 1.7333
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | KMB | Argus | Hold | Buy | -- | $120 | Nov. 13, 2025 |
| Downgrade | KMB | Evercore ISI | Outperform | In-line | -- | $120 | Nov. 4, 2025 |
| Upgrade | KMB | JP Morgan | Underweight | Neutral | -- | $138 | Aug. 4, 2025 |
| Resumed | KMB | Piper Sandler | -- | Overweight | -- | $144 | July 18, 2025 |
| Downgrade | KMB | TD Cowen | Buy | Hold | -- | $145 | Jan. 8, 2025 |
News
Huggies Donates 15 Million Diapers in 15 Days in Celebration of National Diaper Bank Network's 15th Anniversary
Published: January 15, 2026 by: PRNewsWire
Sentiment: Neutral
CHICAGO, Jan. 15, 2026 /PRNewswire/ -- Huggies®, a Kimberly-Clark brand, is teaming up with the National Diaper Bank Network (NDBN) to deliver 15 million donated Huggies diapers in 15 days to celebrate the 15-year anniversary of the national nonprofit. This milestone donation marks the beginning of a recently expanded partnership, where Huggies, the founding sponsor of NDBN, will donate a total of 75 million diapers to the network over 3 years.
Read More
Here's 7 Ideal "Safer" January Dividend Dogs In The S&P500
Published: January 14, 2026 by: Seeking Alpha
Sentiment: Positive
Seven S&P 500 high-yield 'safer' dividend stocks—like Ford, AT&T, and VICI—offer strong payouts supported by free cash flow and attractive valuations. Analyst projections indicate 22.78% to 36.88% net gains for the top ten S&P 500 dividend dogs by January 2027, with average risk 16% below the market. Nine of the top ten S&P 500 dividend dogs already meet the ideal of annual dividends from $1K invested exceeding their share price, signaling fair or undervalued entry points.
Read More
Onvation with SmartFit™ Technology from Kimberly-Clark Professional™ Wins 2026 IoT Breakthrough Award
Published: January 07, 2026 by: GlobeNewsWire
Sentiment: Neutral
Prestigious Annual Awards Program Celebrates a Decade of Recognizing Top Internet-of-Things Innovators Around the Globe Prestigious Annual Awards Program Celebrates a Decade of Recognizing Top Internet-of-Things Innovators Around the Globe
Read More
5 Best Passive Income Dividend Kings With Yields Up to 7% to Buy in 2026
Published: January 05, 2026 by: 24/7 Wall Street
Sentiment: Positive
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream and offer a promising avenue for total return.
Read More
Best Dividend Aristocrats For January 2026
Published: December 31, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Read More
Is KMB's Brand Investment Strategy Enhancing Its Competitive Edge?
Published: December 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly-Clark's disciplined brand reinvestment is driving sustained volume-plus-mix growth, share gains, and margin expansion despite cost pressures.
Read More
Is KMB's Powering Care Strategy Building a Competitive Edge Into 2026?
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly-Clark's Powering Care strategy is driving volume-plus-mix growth, stronger innovation cycles and margin ambitions as it heads into 2026.
Read More
KMB vs. PG: Which Consumer Staples Stock Offers Better Upside Now?
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Procter & Gamble's scale and cash flow strength contrast with Kimberly-Clark's execution-heavy recovery, shaping the upside debate in staples.
Read More
Can Premiumization Keep KMB Growing Ahead of Category Trends?
Published: December 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
Kimberly-Clark's Q3 2025 results show premiumization, driving a seventh straight quarter of volume-plus-mix growth despite pressured categories.
Read More
KMB Stock Tumbles 19% in 3 Months: Buy the Dip or Stay Cautious?
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Kimberly-Clark slides 19% in three months as soft demand, currency pressure and heavy promotions weigh on margins and sentiment.
Read More
Is the Options Market Predicting a Spike in Kimberly-Clark Stock?
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to KMB stock based on the movements in the options market lately.
Read More
5 Blue Chip Stocks to Buy Now That Pay Reliable 4%+ Dividends
Published: December 10, 2025 by: 24/7 Wall Street
Sentiment: Positive
Investors love high-yield dividend stocks, especially the blue chip variety, because they offer a significant income stream and have massive total return potential.
Read More
The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026
Published: December 09, 2025 by: 24/7 Wall Street
Sentiment: Positive
Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.
Read More
Kimberly-Clark Progresses Toward Its Gross Margin Goal of 40%
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive
KMB's Q3 progress boosts confidence that it can hit its 40% gross margin goal sooner as mix gains and cost cuts strengthen profitability.
Read More
Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out
Published: December 05, 2025 by: Seeking Alpha
Sentiment: Positive
Kimberly-Clark is acquiring Kenvue in a $48.7 billion cash-and-stock deal. I believe the deal is likely to close, and that Kenvue stock gives folks a decent way to buy Kimberly-Clark at a discount. There is still a solid deal spread here, and I think Kimberly-Clark is undervalued as well, offering additional upside once the deal closes.
Read More
Kimberly-Clark Corporation (KMB) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Published: December 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation (KMB) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Read More
KMB Accelerates Growth Through Digital & Club Channel Expansion
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Kimberly powers growth through surging digital sales and strong club channel gains as shoppers seek convenience and value.
Read More
Kimberly-Clark: An Undervalued Dividend Aristocrat For Income-Seeking Investors
Published: November 24, 2025 by: Seeking Alpha
Sentiment: Positive
Kimberly-Clark, an American multinational consumer goods and personal care corporation, is now a $34 billion (by market cap) consumer products leader. On November 3, Kimberly-Clark announced a $48.7 billion deal to acquire Kenvue Inc. KMB increased its dividend for 53 consecutive years, with a 10-year dividend growth rate of 4%.
Read More
4 Highest Yielding Dividend Stocks in the Nasdaq Composite
Published: November 12, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend stocks might not sound like an exciting investment in your portfolio, but if you can invest in the right ones, they can generate years of passive income.
Read More
Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56
Published: November 10, 2025 by: Seeking Alpha
Sentiment: Positive
The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by November 2026, with Stepan, H2O America, and National Fuel Gas among the top projections.
Read More
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction
Published: November 05, 2025 by: MarketBeat
Sentiment: Neutral
On Nov. 3rd, Wall Street rendered a swift and brutal verdict on Kimberly-Clark's NASDAQ: KMB transformative acquisition of Kenvue NYSE: KVUE. While Kenvue's shares climbed over 12%, Kimberly-Clark's stock price dropped more than 14% to a new 52-week low, wiping out approximately $5.8 billion in market value in a single trading session.
Read More
3 Dividend Stocks for November 2025
Published: November 04, 2025 by: Morningstar
Sentiment: Neutral
This month's trio includes two ADRs.
Read More
Kimberly-Clark Corporation (KMB) M&A Call Transcript
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Kimberly-Clark Corporation ( KMB ) M&A Call November 3, 2025 8:00 AM EST Company Participants Christopher Jakubik - Investor Relations Contact Michael Hsu - Chairman & CEO Kirk Perry - Interim CEO & Director Sherilyn S. McCoy Nelson Urdaneta - Senior VP & CFO Conference Call Participants Nik Modi - RBC Capital Markets, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Dara Mohsenian - Morgan Stanley, Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Javier Escalante Manzo - Evercore ISI Institutional Equities, Research Division Presentation Operator Good morning.
Read More
Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More
Published: November 03, 2025 by: Investopedia
Sentiment: Positive
Major U.S. equities indexes were mixed Monday afternoon, as tech stocks gained but most other sectors declined. The S&P 500 and Nasdaq rose, while the Dow fell.
Read More
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger
Published: November 03, 2025 by: The Street
Sentiment: Positive
The deal would bring Huggies, Kleenex, Band-Aid, Neutrogena, and Tylenol under one roof, creating a consumer staples giant. Transcript: Caroline Woods: Big brands and big money - Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock deal.
Read More
Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know
Published: November 03, 2025 by: Investopedia
Sentiment: Positive
Kenvue (KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark (KMB) said it's buying the Tylenol maker in a $48.7 billion deal.
Read More
Kimberly-Clark to acquire Tylenol-maker Kenvue in $48.7B deal
Published: November 03, 2025 by: Proactive Investors
Sentiment: Positive
Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in a cash and stock transaction valued at approximately $48.7 billion. Under the agreement, Kenvue shareholders will receive $3.50 per share in cash plus 0.14625 Kimberly-Clark shares for each Kenvue share, totaling $21.01 per share based on Kimberly-Clark's recent stock price.
Read More
Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal
Published: November 03, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
Kimberly-Clark agreed to buy Kenvue in a deal worth roughly $40 billion in a combination that could create a company with $32 billion in revenue and allow it to surpass Unilever to become the second-biggest seller of health and wellness products after Procter & Gamble. Eric Pfanner reports on Bloomberg Television.
Read More
Tylenol Maker Eyes Best Day Ever on Kimberly-Clark Deal
Published: November 03, 2025 by: Schaeffers Research
Sentiment: Positive
Tylenol maker and former Johnson & Johnson (JNJ) spinoff Kenvue Inc (NYSE:KVUE) is 16.7% higher to trade at $16.74, after Kimberly-Clark Corp (NASDAQ:KMB) agreed to purchase the pharma name for $48.70 billion in cash and stock.
Read More
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Published: November 03, 2025 by: New York Post
Sentiment: Positive
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Read More
About Kimberly-Clark Corporation (KMB)
- IPO Date 1980-03-17
- Website https://www.kimberly-clark.com
- Industry Household & Personal Products
- CEO Michael D. Hsu
- Employees 38000